Amicus Therapeutics Announces First Quarter 2017 Financial Results and Corporate Updates
May 09, 2017 11:32 am UTC| Business
100+ Fabry Disease Patients Now on Reimbursed Galafold (migalastat) in the EU On Target to Reach 300 Patients on Galafold by Year-End 2017 Additional Important Phase 1/2 Pompe Clinical Data Expected in 2Q17 and 3Q17 ...
Amicus Therapeutics Announces First Quarter 2017 Financial Results and Corporate Updates
May 09, 2017 11:32 am UTC| Business
100+ Fabry Disease Patients Now on Reimbursed Galafold (migalastat) in the EU On Target to Reach 300 Patients on Galafold by Year-End 2017 Additional Important Phase 1/2 Pompe Clinical Data Expected in 2Q17 and 3Q17 ...
Amicus Therapeutics Announces First Quarter 2017 Financial Results and Corporate Updates
May 09, 2017 11:32 am UTC| Business
100+ Fabry Disease Patients Now on Reimbursed Galafold (migalastat) in the EU On Target to Reach 300 Patients on Galafold by Year-End 2017 Additional Important Phase 1/2 Pompe Clinical Data Expected in 2Q17 and 3Q17 ...
Synalloy Reports First Quarter 2017 Results: Sales Increase Drives a Return to Profitability
May 09, 2017 11:32 am UTC| Business
RICHMOND, Va., May 09, 2017 -- Synalloy Corporation (Nasdaq:SYNL), today announced net sales for the first quarter of 2017 of $42.2 million. This represents an increase of $5.9 million or 16% when compared to net sales...
Synalloy Reports First Quarter 2017 Results: Sales Increase Drives a Return to Profitability
May 09, 2017 11:32 am UTC| Business
RICHMOND, Va., May 09, 2017 -- Synalloy Corporation (Nasdaq:SYNL), today announced net sales for the first quarter of 2017 of $42.2 million. This represents an increase of $5.9 million or 16% when compared to net sales...
Synalloy Reports First Quarter 2017 Results: Sales Increase Drives a Return to Profitability
May 09, 2017 11:32 am UTC| Business
RICHMOND, Va., May 09, 2017 -- Synalloy Corporation (Nasdaq:SYNL), today announced net sales for the first quarter of 2017 of $42.2 million. This represents an increase of $5.9 million or 16% when compared to net sales...
Avadel Pharmaceuticals Reports First Quarter 2017 Results
May 09, 2017 11:31 am UTC| Business
DUBLIN, Ireland, May 09, 2017 -- Avadel Pharmaceuticals plc (NASDAQ:AVDL) today announced its financial results for the first quarter of 2017. Highlights Include: Total revenues for the first quarter 2017 were $52.5...
Threading Opportunity: How an India–EU FTA Could Reweave Textile Fortunes